The invention is a mixture for parenteral use comprising sodium ions, chlorine ions, potassium ions, macronutrients.
| Patent title | Miscele nutrizionali |
|---|---|
| Thematic area | Health |
| Ownership | ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA |
| Inventors | Loris Pironi |
| Protection | Italy |
| Licensing status | Available for development agreements, option, license and other exploitation agreements |
| Keywords | Chronic intestinal failure, short bowel syndrome, home parenteral nutrition or long-term parenteral nutrition, premixed parenteral nutrition admixtures, fluid and electrolytes balance |
| Filed on | 31 July 2013 |
Artificial Nutrition (AN) is a complex of procedures by which it is possible to meet the nutritional needs of patients unable to feed themselves sufficiently naturally, as in the case of patients with benign chronic intestinal insufficiency (BCII). On the market there are nutritional solutions and emulsions (nutritional mixtures) with standard content or with a composition in nutrients such as amino acids, glucose, lipids, electrolytes, etc. well defined and considered adequate to meet the needs of most patients who require parenteral nutrition in the hospital setting. However, commercially available standard mixtures have, in particular, an electrolyte content that is not sufficient to meet the needs of patients with intestinal insufficiency characterized by high intestinal losses of electrolytes. It follows that in these subjects, the use of standard mixtures for parenteral nutrition (NP) currently on the market is associated with the concrete risk of developing electrolyte deficiencies.
The invention refers to a standardized mixture for parenteral use aimed at satisfying the nutritional needs of a wide range of patients with intestinal insufficiency (very heterogeneous pathological condition) characterized by an electrolyte composition suitable for guaranteeing an adequate supply of the latter to said patients, and in particular, in those patients in which significant intestinal losses of electrolytes are observed.
Advantages:
a) administration advantageous for patients, as it reduces the number of "management maneuvers" of the infusion line, reduces the risk of electrolyte deficiencies and infections related to the infusion line
b) facilitated assistance, both medical and nursing, as it reduces the use of the prescription of galenic formulas and simplifies the delivery of therapy
c) reduction of therapy costs, as a standard mixture has lower costs than a galenic or an “integrated” standard.